References
Key articles
Marimoutou C, Ferraro J, Javelle E, et al. Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist six years later. Clin Microbiol Infect. 2015 Jul;21(7):688-93.Full text Abstract
Burt FJ, Chen W, Miner JJ, et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017 Apr;17(4):e107-17. Abstract
Brito CA, Sohsten AK, Leitão CC, et al. Pharmacologic management of pain in patients with chikungunya: a guideline. Rev Soc Bras Med Trop. 2016 Nov-Dec;49(6):668-79.Full text Abstract
Burt FJ, Rolph MS, Rulli NE, et al. Chikungunya: a re-emerging virus. Lancet. 2012 Feb 18;379(9816):662-71. Abstract
World Health Organization. Guidelines on clinical management of Chikungunya fever. October 2008 [internet publication].Full text
Gérardin P, Fianu A, Michault A, et al. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013 Jan 9;15(1):R9.Full text Abstract
Reference articles
1. Uniprot. Structural polyprotein: chikungunya virus (strain S27-African prototype) (CHIKV). September 2015 [internet publication].Full text
2. Tsetsarkin KA, Chen R, Sherman MB, et al. Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol. 2011 Oct;1(4):310-7.Full text Abstract
3. Tsetsarkin KA, Chen R, Leal G, et al. Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7872-7.Full text Abstract
4. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep;62(9):2569-81.Full text Abstract
5. Marimoutou C, Ferraro J, Javelle E, et al. Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist six years later. Clin Microbiol Infect. 2015 Jul;21(7):688-93.Full text Abstract
6. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955 Jan;49(1):28-32. Abstract
7. Pialoux G, Gaüzère BA, Jauréguiberry S, et al. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007 May;7(5):319-27.Full text Abstract
8. Staples JE, Fischer M. Chikungunya virus in the Americas: what a vectorborne pathogen can do. N Engl J Med. 2014 Sep 4;371(10):887-9.Full text Abstract
9. Burt FJ, Chen W, Miner JJ, et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017 Apr;17(4):e107-17. Abstract
10. Pan American Health Organization. Chikungunya: PAHO/WHO data, maps and statistics. December 2017 [internet publication].Full text
11. European Centre for Disease Prevention and Control. Chikungunya virus disease - annual epidemiological report for 2017. April 2019 [internet publication].Full text
12. Centers for Disease Control and Prevention. Chikungunya virus 2018 data. January 2019 [internet publication].Full text
13. Kuehn BM. After Chikungunya virus transmission detected in United States, health authorities brace for wider spread. July 2014 [internet publication].Full text
14. World Health Organization. Disease outbreak news: chikungunya – Mombasa, Kenya. February 2018 [internet publication].Full text
15. World Health Organization. Disease outbreak news: chikungunya – Sudan. October 2018 [internet publication].Full text
16. World Health Organization. Disease outbreak news. Chikungunya - Congo. May 2019 [internet publication].Full text
17. Fischer D, Thomas SM, Suk JE, et al. Climate change effects on Chikungunya transmission in Europe: geospatial analysis of vector's climatic suitability and virus' temperature requirements. Int J Health Geogr. 2013 Nov 12;12:51.Full text Abstract
18. Powers AM, Brault AC, Tesh RB, et al. Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol. 2000 Feb;81(Pt 2):471-9. Abstract
19. Higgs S, Vanlandingham D. Chikungunya virus and its mosquito vectors. Vector Borne Zoonotic Dis. 2015 Apr;15(4):231-40. Abstract
20. Tsetsarkin KA, Vanlandingham DL, McGee CE, et al. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007 Dec;3(12):e201.Full text Abstract
21. Centers for Disease Control and Prevention. Chikunguny: information for vector control programs. March 2015 [internet publication].Full text
22. Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010 Jul;8(7):491-500. Abstract
23. Her Z, Malleret B, Chan M, et al. Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol. 2010 May 15;184(10):5903-13.Full text Abstract
24. Mowatt L, Jackson ST. Chikungunya in the Caribbean: an epidemic in the making. Infect Dis Ther. 2014 Dec;3(2):63-8.Full text Abstract
25. Larrieu S, Pouderoux N, Pistone T, et al. Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol. 2010 Jan;47(1):85-8. Abstract
26. Nakkhara P, Chongsuvivatwong V, Thammapalo S. Risk factors for symptomatic and asymptomatic chikungunya infection. Trans R Soc Trop Med Hyg. 2013 Dec;107(12):789-96.Full text Abstract
27. Li Y, Kamara F, Zhou G, et al. Urbanization increases Aedes albopictus larval habitats and accelerates mosquito development and survivorship. PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3301.Full text Abstract
28. Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med. 2008 Mar 18;5(3):e60.Full text Abstract
29. Thiboutot MM, Kannan S, Kawalekar OU, et al. Chikungunya: a potentially emerging epidemic? PLoS Negl Trop Dis. 2010 Apr 27;4(4):e623.Full text Abstract
30. Sissoko D, Moendandze A, Malvy D, et al. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One. 2008 Aug 26;3(8):e3066.Full text Abstract
31. Petersen LR, Epstein JS. Chikungunya virus: new risk to transfusion safety in the Americas. Transfusion. 2014 Aug;54(8):1911-5. Abstract
32. Lokireddy S, Sarojamma V, Ramakrishna V. Genetic predisposition to chikungunya - a blood group study in chikungunya affected families. Virol J. 2009 Jun 16;6:77.Full text Abstract
33. Yaseen HM, Simon F, Deparis X, et al. Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes. BMC Musculoskelet Disord. 2014 Jul 24;15:249.Full text Abstract
34. Reisinger EC, Tschismarov R, Beubler E, et al. Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. Lancet. 2018 Dec 22;392(10165):2718-2727. Abstract
35. ClinicalTrials.gov. Trial of a chikungunya vaccine, PXVX0317 CHIKV-VLP, in healthy adults. June 2018 [internet publication].Full text
36. Brito CA, Sohsten AK, Leitão CC, et al. Pharmacologic management of pain in patients with chikungunya: a guideline. Rev Soc Bras Med Trop. 2016 Nov-Dec;49(6):668-79.Full text Abstract
37. Simon F, Javelle E, Oliver M, et al. Chikungunya virus infection. Curr Infect Dis Rep. 2011 Jun;13(3):218-28.Full text Abstract
38. Burt FJ, Rolph MS, Rulli NE, et al. Chikungunya: a re-emerging virus. Lancet. 2012 Feb 18;379(9816):662-71. Abstract
39. Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis. 2009 Dec 10;9:200.Full text Abstract
40. Chopra A, Anuradha V, Lagoo-Joshi V, et al. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 2008 Sep;58(9):2921-2.Full text Abstract
41. Rodriguez-Morales AJ, Cardona-Ospina JA, Villamil-Gómez W, et al. How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America? Rheumatol Int. 2015 Dec;35(12):2091-4. Abstract
42. Niedrig M, Zeller H, Schuffenecker I, et al. International diagnostic accuracy study for the serological detection of chikungunya virus infection. Clin Microbiol Infect. 2009 Sep;15(9):880-4.Full text Abstract
43. Centers for Disease Control and Prevention. New CDC laboratory test for Zika virus authorized for emergency use by FDA. March 2016 [internet publication].Full text
44. Dash M, Mohanty I, Padhi S. Laboratory diagnosis of chikungunya virus: do we really need it? Indian J Med Sci. 2011 Mar;65(3):83-91. Abstract
45. Blacksell SD, Tanganuchitcharnchai A, Jarman RG, et al. Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infection. Clin Vaccine Immunol. 2011 Oct;18(10):1773-5.Full text Abstract
46. Tandale BV, Sathe PS, Arankalle VA, et al. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol. 2009 Oct;46(2):145-9. Abstract
47. Ganesan K, Diwan A, Shankar SK, et al. Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1 case with autopsy findings. AJNR Am J Neuroradiol. 2008 Oct;29(9):1636-7.Full text Abstract
48. Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009 Dec;76(6):654-7. Abstract
49. Chaaithanya IK, Muruganandam N, Raghuraj U, et al. Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection. Indian J Med Res. 2014 Jul;140(1):142-5.Full text Abstract
50. World Health Organization; Pan American Health Organization. Tool for the diagnosis and care of patients with suspected arboviral diseases. 2017 [internet publication].Full text
51. World Health Organization. Guidelines on clinical management of Chikungunya fever. October 2008 [internet publication].Full text
52. Arroyo-Ávila M, Cabán A, García-Rivera EJ, et al. Clinical manifestations associated with peripheral joint involvement in patients with acute chikungunya virus infection. Am J Trop Med Hyg. 2017 Apr;96(4):916-21.Full text Abstract
53. Murthy J. Chikungunya virus: the neurology. Neurol India. 2009 Mar-Apr;57(2):113-5.Full text Abstract
54. Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013 Feb 11;3(1):35. Abstract
55. Sarkar JK, Chatterjee SN, Chakravarti SK, et al. Chikungunya virus infection with haemorrhagic manifestations. Indian J Med Res. 1965 Oct;53(10):921-5. Abstract
56. Laoprasopwattana K, Kaewjungwad L, Jarumanokul R, et al. Differential diagnosis of Chikungunya, dengue viral infection and other acute febrile illnesses in children. Pediatr Infect Dis J. 2012 May;31(5):459-63.Full text Abstract
57. California Department of Public Health. Health and travel advisory: chikungunya and dengue in Mexico and Latin America. February 2015 [internet publication].Full text
58. Centers for Disease Control and Prevention. Zika virus: overview. August 2017 [internet publication].Full text
59. European Centre for Disease Prevention and Control. Information for health practitioners: chikungunya virus. January 2008 [internet publication].Full text
60. Godaert L, Najioullah F, Bousquet L, et al. Do two screening tools for chikungunya virus infection that were developed among younger population work equally as well in patients aged over 65 years? PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005256.Full text Abstract
61. Direction Generale de la Sante. National recommendations on the management of Chikungunya [in French]. November 2014 [internet publication].Full text
62. Padmakumar B, Jayan JB, Menon R, et al. Comparative evaluation of four therapeutic regimes in chikungunya arthritis: a prospective randomized parallel-group study. Indian J Rheumatol. 2009 Sep;4(3):94-101.
63. Gaujoux-Viala C, Gossec L, Cantagrel A, et al. Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis. Joint Bone Spine. 2014 Jul;81(4):287-97.Full text Abstract
64. Ganu MA, Ganu AS. Post-chikungunya chronic arthritis-our experience with DMARDs over two year follow up. J Assoc Physicians India. 2011 Feb;59:83-6. Abstract
65. Amaral JK, Sutaria R, Schoen RT. Treatment of chronic chikungunya arthritis with methotrexate: a systematic review. Arthritis Care Res (Hoboken). 2018 Oct;70(10):1501-8. Abstract
66. Wendling D, Lukas C, Paccou J, et al. Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis. Joint Bone Spine. 2014 Jan;81(1):6-14.Full text Abstract
67. Ribéra A, Degasne I, Jaffar Bandjee MC, et al. Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic considerations [in French]. Med Trop (Mars). 2012 Mar;72 Spec No:83-5. Abstract
68. Brighton SW. Chloroquine phosphate treatment of chronic Chikungunya arthritis: an open pilot study. S Afr Med J. 1984 Aug 11;66(6):217-8.Full text Abstract
69. De Lamballerie X, Boisson V, Reynier JC, et al. On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis. 2008 Dec;8(6):837-9. Abstract
70. Chopra A, Saluja M, Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 2014 Feb;66(2):319-26.Full text Abstract
71. Ravichandran R, Manian M. Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries. 2008 Apr 1;2(2):140-2. Abstract
72. Dagley A, Ennis J, Turner JD, et al. Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Res. 2014 Aug;108:1-9.Full text Abstract
73. Briolant S, Garin D, Scaramozzino N, et al. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res. 2004 Feb;61(2):111-7. Abstract
74. Delogu I, Pastorino B, Baronti C, et al. In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Antiviral Res. 2011 Jun;90(3):99-107. Abstract
75. Ozden S, Lucas-Hourani M, Ceccaldi PE, et al. Inhibition of Chikungunya virusinfection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J Biol Chem. 2008 Aug 8;283(32):21899-908. Abstract
76. Pohjala L, Utt A, Varjak M, et al. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One. 2011;6(12):e28923.Full text Abstract
77. Kaur P, Thiruchelvan M, Lee RC, et al. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother. 2013 Jan;57(1):155-67.Full text Abstract
78. Khan M, Dhanwani R, Patro IK, et al. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells. Antiviral Res. 2011 Jan;89(1):1-8. Abstract
79. Lee RC, Hapuarachchi HC, Chen KC, et al. Mosquito cellular factors and functions in mediating the infectious entry of chikungunya virus. PLoS Negl Trop Dis. 2013;7(2):e2050.Full text Abstract
80. Li YG, Siripanyaphinyo U, Tumkosit U, et al. Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells. Virol J. 2012 Jun 14;9:114.Full text Abstract
81. Parashar D, Paingankar MS, Kumar S, et al. Administration of E2 and NS1 siRNAs inhibit chikungunya virusreplication in vitro and protects mice infected with the virus. PLoS Negl Trop Dis. 2013 Sep 5;7(9):e2405.Full text Abstract
82. Dash PK, Tiwari M, Santhosh SR, et al. RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells. Biochem Biophys Res Commun. 2008 Nov 28;376(4):718-22. Abstract
83. Bourjot M, Leyssen P, Neyts J, et al. Trigocherrierin A, a potent inhibitor of chikungunya virus replication. Molecules. 2014 Mar 24;19(3):3617-27.Full text Abstract
84. Teo TH, Chan YH, Lee WW, et al. Fingolimod treatment abrogates chikungunya virus-induced arthralgia. Sci Transl Med. 2017 Feb 1;9(375):eaal1333. Abstract
85. Miner JJ, Cook LE, Hong JP, et al. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis. Sci Transl Med. 2017 Feb 1;9(375):eaah3438. Abstract
86. Mavalankar D, Shastri P, Bandyopadhyay T, et al. Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis. 2008 Mar;14(3):412-5.Full text Abstract
87. Goupil BA, Mores CN. A review of chikungunya virus-induced arthralgia: clinical manifestations, therapeutics, and pathogenesis. Open Rheumatol J. 2016 Nov 30;10:129-40.Full text Abstract
88. Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137.Full text Abstract
89. Gérardin P, Fianu A, Michault A, et al. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013 Jan 9;15(1):R9.Full text Abstract
90. Couturier E, Guillemin F, Mura M, et al. Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. Rheumatology (Oxford). 2012 Jul;51(7):1315-22.Full text Abstract
91. Edington F, Varjão D, Melo P. Incidence of articular pain and arthritis after chikungunya fever in the Americas: a systematic review of the literature and meta-analysis. Joint Bone Spine. 2018 Jul 24 [Epub ahead of print]. Abstract
Use of this content is subject to our disclaimer